BRIEF-Capgemini Gets Regulatory Approvals For WNS Acquisition-March 2024-www.financetom.com

BRIEF-Capgemini Gets Regulatory Approvals For WNS Acquisition

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Capgemini Gets Regulatory Approvals For WNS Acquisition

Sep 17, 2025 10:07 AM

Sept 17 (Reuters) - Capgemini SE:

* CAPGEMINI OBTAINS ALL REGULATORY APPROVALS FOR THE

ACQUISITION

OF WNS

* DEAL SUBJECT TO ROYAL COURT OF JERSEY SANCTION

* CLOSING EXPECTED BY END OF OCTOBER 2025

* TO BUY WNS FOR $76.50 PER SHARE

* TOTAL CASH CONSIDERATION $3.3 BILLION EXCLUDING WNS DEBT

Source text:

Further company coverage:

(Gdansk Newsroom)

Previous page： Globus Medical Gains US FDA Clearance for Robotic Navigation Platform, Knee Implant System Next page： Adidas and Thom Browne fight in UK court over striped trademarks

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Globus Medical Gains US FDA Clearance for Robotic Navigation Platform, Knee Implant System

Jul 17, 2024

09:07 AM EDT, 07/17/2024 (MT Newswires) -- Globus Medical ( GMED ) said Wednesday that it has received the US Food and Drug Administration's 510(k) clearance for its ExcelsiusFlex robotic navigation platform and the Actify 3D total knee replacement system. The ExcelsiusFlex assists surgeons in performing knee arthroplasty procedures, while the Actify 3D system is a knee implant that combines...

Adidas and Thom Browne fight in UK court over striped trademarks

Jul 17, 2024

LONDON (Reuters) - Athletic wear giant Adidas and fashion house Thom Browne resumed their legal battle on Wednesday, with London's High Court hearing the latest round of a global dispute focused on their competing striped trademarks. New York designer Thom Browne, who regularly uses a four-bar stripe pattern, sued Adidas in London in 2021 to revoke several trademarks featuring Adidas'...

Gilead Sciences Chief Medical Officer Merdad Parsey to Leave

Jul 17, 2024

09:09 AM EDT, 07/17/2024 (MT Newswires) -- Gilead Sciences ( GILD ) said Wednesday that its chief medical officer, Dr. Merdad Parsey, will depart early next year. The company said Parsey will remain in his role until Q1 of next year while Gilead searches for a replacement. Price: 72.00, Change: +0.36, Percent Change: +0.50 ...

Prologis raises annual core FFO forecast on better demand, data center strength

Jul 17, 2024

(Reuters) - Warehouse-focused real estate investment trust (REIT) Prologis ( PLD ) raised the lower end of its full-year forecast for core funds from operations (FFO) on Wednesday, banking on better demand and strength from data centers. Prologis ( PLD ), which focuses on logistics real estate, expects its 2024 core FFO to be between $5.39 and $5.47 per share,...